R&D

KOOKMIN BIO

ㅣLaboratory

Kookmin Bio microbiome technology research institute owns research capacity and technology accumulated over all processes of bioindustry - including searching bio food and medicine material and new drug candidate, mass production of bio food and medicine, item permissions, product characteristics, and effect mechanism research - with the basis of microbiome-controlling innovative platform technology

Microbiome-Controlling
Biohealth Food & Drugs Material
Development Leading Company


Kookmin Bio Co., Ltd., is establishing portfolio of microbiome-controlling biohealth food and medicine 

with innvoative microbiome platform technology to treat geriatic illness, degenerative diseases, colorectal cancer, etc.

Korea's Best R&D Experts
60% of Total Employees
Leading Technology and Capability of 
Incubating Process / Refining Process Development
Cutting-Edge Research Equipment 
efficiency verification
Platform Technology,
the Key Basis Technology Accumulated
ㅣLaboratory

Kookmin Bio microbiome technology research institute owns research capacity and technology accumulated over all processes of bioindustry
 - including searching bio food and medicine material and new drug candidate, mass production of bio food and medicine, item permissions, product characteristics, and effect mechanism research - with the basis of microbiome-controlling innovative platform technology


 01 
Establishment
of Detailed DB

Detailed Medical-Based DB is

Established via Large-Scale

Detailed Microbiome Profiling.





 02 
Candidate Substance
Discovery

We Build the Entry Barrier with Safety-Guaranteed and Exclusive Candidate

Substance via Natural Material

and GRAS Microbiome.




 03 
Effect
Verification

Via Cell Line Screening, Development Candidates and Effective

Substances' Effects are

Verified and Discovered




 04 
Effects/Mechanism
Assessment

Sickness Mechanism Research,

Effects Assessment and New Target

Discovery via Animal Assessments

of Sicknesses



Microbiome-Controlling Biohealth Food & Drugs Material  Development Leading Company

Kookmin Bio Co., Ltd., is establishing portfolio of microbiome-controlling biohealth food and medicine 

with innvoative microbiome platform technology to treat geriatic illness, degenerative diseases, colorectal cancer, etc.


Owns Separate Research Facility -
BL-2 Bio Safety Level 2

for Microbiome Controlling Bio Food and Medicine Development

Korea's Best R&D Experts
60% of Total Employees
Leading Technology and Capability of
Incubating Process /
 Refining Process Development
Cutting-Edge Research Equipment 
for microorganism biochemistry and
in-virtro-in-vivo efficiency verification
Platform Technology
the Key Basis Technology Accumulated
for Microbiome Controlling Bio Food and Medicine Development
BL-2 Bio Safety Level 2

Owns Separate Research Facility

Do you have any questions? Enter a keyword.
Do you have any questions? Enter a keyword.

Kookmin Bio Co., Ltd. 

Headquarter   Rm#116, Main building of Jeonju University, 303, Cheonjam-ro, Wansan-gu, Jeonju-si, Jeollabuk-do 
Microbiome technology research institute / Seoul Subsidiary   1,2,3FL, Cheongam building, 51-2, Arirang-ro, Seongbuk-gu, Seoul | TEL 02 927 2024 | FAX 02 927 2025

BIO food and drub material commercialization center / GMP Factory    Foodpolis-ro 9-gil, Wanggung-myeong, Iksan-si, Jeollabuk-do | TEL 064 833 2024 | 063 834 2025

Copyright ⓒ 2021 Kookmin Bio Co., Ltd.  All rights reserved.